Navigation Links
CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
Date:8/28/2007

rights, as well as those risks, uncertainties and factors more fully disclosed in the 'Risk Factors' section of CuraGen's Quarterly Report on Form 10-Q for the quarter ended June 30, 2007, filed with the Securities and Exchange Commission, as well as other documents that may be filed by CuraGen from time to time with the Securities and Exchange Commission. As a result of such risks, uncertainties and factors, CuraGen's actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward-looking statements contained herein. CuraGen is providing the information in this press release as of this date and assumes no obligations to update the information included in this press release or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CuraGen Contact:

Glenn Schulman, Pharm.D.

Director of Investor Relations

gschulman@curagen.com

(888) 436-6642

CRGN-P


'/>"/>
SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CuraGen Presents Update on Clinical Development Program for Belinostat
2. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
3. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
4. Malvern initiates European user group meetings for chemical imaging
5. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
6. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
7. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... ANGELES , April 21, 2015  Legal-Bay ... that Pradaxa,s maker, Boehringer Ingelheim Pharmaceuticals, is seeking ... DVT and PE. According to PBR, Boehringer submitted ... FDA in hopes that Pradaxa will be approved ... and pulmonary embolism (PE) for patients who have ...
(Date:4/20/2015)... 2015  Following is the daily "Profile America" feature ... MEDICINE Profile America — ... insulin —became available for general use this month in ... from diabetes. Insulin is a hormone produced by the ... in the human body. It was first isolated the ...
(Date:4/20/2015)... - Dr. Gregory Taylor , Canada,s ... today after spending a week in West Africa ... and needs on the ground as global efforts continue to reach ... and prevention efforts in Sierra Leone and ... see first-hand the work being done and hear from those on ...
Breaking Medicine Technology:Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 2Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 3U.S. Census Bureau Daily Feature for April 21 2Canada's Efforts Making a Difference in the Fight Against Ebola 2Canada's Efforts Making a Difference in the Fight Against Ebola 3Canada's Efforts Making a Difference in the Fight Against Ebola 4Canada's Efforts Making a Difference in the Fight Against Ebola 5
(Date:4/21/2015)... TN (PRWEB) April 21, 2015 ... clinical services and provider of Picture Archiving and ... area with four new installations in the first ... Springs, KY), Pinnacle Orthopaedics (McMinnville, TN) and Lowcountry ... the ProtonPACS viewer and data archiving services. Mt. ...
(Date:4/21/2015)... One of the most difficult aspects of ... cravings. Many diets end badly due to dieters’ inability ... attempt to eat more often throughout the day, portioning ... intervals. While this approach does work for many, others ... a meal. For those who are having trouble remaining ...
(Date:4/21/2015)... The University of Scranton has ... Informatics to answer the growing demand for professionals ... comprehensive wellness profile for better individual, real-world care. ... and implementation of health services and systems. This ... managerial operations in the healthcare sector,” says Margarete ...
(Date:4/21/2015)... TX (PRWEB) April 21, 2015 ... is actively involved in various components of breast ... fields. , "Breast reconstruction research continues ... mastectomy. Despite recent advances, many unanswered questions ... provide patients with optimal results," says Dr. Oscar ...
(Date:4/21/2015)... April 21, 2015 CALNOC, the nation’s ... Bolton, DrPH, RN, FAAN, will keynote their upcoming conference ... Long Beach, CA on October 26, 2015. , ... American Organization of Nurse Executives (AONE) and the first ... of the American Academy of Nursing and the National ...
Breaking Medicine News(10 mins):Health News:Radsource Adds 4 ProtonPACS Clients in 1st Quarter 2Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 2Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 3Health News:The University of Scranton Launches Online MS in Health Informatics 2Health News:The University of Scranton Launches Online MS in Health Informatics 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:Nationally Recognized Nurse Leader Linda Burnes Bolton to Present Keynote Address at CALNOC Conference 2
... are, the more accurate a picture you get when you ... ability to simultaneously measure as many as 100 or more ... disease such as cancer, that capability would provide a much ... , A Stanford University School of Medicine team led by ...
... Industries, Inc. ( www.sanitecindustries.com ),the global patent holder ... Disinfection System(TM), has successfully emerged from its Chapter ... for the Central District of California ruled yesterday ... Industries should be confirmed thus clearing the way ...
... has successfully implemented TransportConnect(TM) at Intuitive Surgical ... DGN Technologies, Inc. announced today that ... Surgical, located in Sunnyvale, California, USA. ... and selected TransportConnect(TM) to address the specific ...
... got milk? Milk Mustache,Mobile Drink Well. Live Well. Tour ... and its array of benefits. The Tour,cruised through Atlanta ... only live well but to drink well with nature,s ... little face of wellness!...Luciano Liberona was very excited to ...
... could reduce related blindness by almost 35%, study suggests, ... rate of age-related macular degeneration is on the increase, ... of the disease by about 35 percent, new estimates ... Centers for Disease Control and Prevention, researchers report that ...
... of Transplantation Joins James Redford on May 30 ... to Raise Transplant Awareness BOSTON, April ... the American Society of Transplantation (AST) will host Share the ... benefit organ donation awareness and transplant research . Share the ...
Cached Medicine News:Health News:Stanford researchers harness nanoparticles to track cancer-cell changes 2Health News:Stanford researchers harness nanoparticles to track cancer-cell changes 3Health News:Sanitec Industries Emerges From Chapter 11 2Health News:DGN Technologies TransportConnect(TM) Successfully Implemented at Intuitive Surgical 2Health News:DGN Technologies TransportConnect(TM) Successfully Implemented at Intuitive Surgical 3Health News:The Hispanic Got Milk? Campaign Recently Visited Atlanta Promoting the Drink Well. Live Well. Tour! 2Health News:Nearly 18 Million Will Have Macular Degeneration by 2050 2Health News:Nearly 18 Million Will Have Macular Degeneration by 2050 3Health News:Country Star Phil Vassar to Perform at Transplantation Fundraiser 2
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: